Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Pain Symptom Manage. 2017 Jan 4;54(2):204–218.e2. doi: 10.1016/j.jpainsymman.2016.12.342

Table 6.

Differences in the Vibration Thresholds, Grip Strength, Pegboard Test, Heel Lift, Balance, and Reflexes in the Dominant Extremities Between Cancer Survivors With (n=426) and Without (n=197) Chemotherapy Induced Neuropathy (CIN)

Site No CIN
31.6% (n=197)
CIN
68.4% (n=426)
t-test,* p-value A
%
B
%
Mean (SD) Mean (SD)
Vibration Thresholds (volts)
Dorsal IP joint of great toe 17.01 (10.64) 25.14 (14.66) −8.06, <.001 1.5 8.0
Medial malleolus 20.98 (11.23) 28.10 (13.53) −6.85, <.001 2.1 9.0
Patella 22.12 (10.80) 27.26 (11.90) −5.31, <.001 1.5 3.3
Dorsal IP joint of thumb 5.19 (2.26) 6.92 (4.56) −6.31, <.001 0.0 0.0
Dorsal IP joint of index finger 5.77 (3.10) 7.44 (4.56) −5.32, <.001 0.0 0.0
Ulnar prominence of the wrist 6.99 (2.81) 9.18 (5.51) −6.52, <.001 0.0 0.0
Lateral epicondyle 10.33 (4.31) 12.71 (6.23) −5.49, <.001 0.0 0.0
Additional Tests
Grip strength (kilograms) 27.70 (8.01) 25.39 (8.28) 3.25, .001 n/a
Number of pins in 30 seconds 14.63 (2.48) 14.04 (2.26) 2.92, .004 n/a
Heel lift (seconds) 14.16 (2.98) 12.63 (4.56) 4.97, <.001 n/a
Timed get up and go test (seconds) 6.57 (1.51) 7.75 (2.49) −7.27, <.001 n/a
Fullerton Advanced Balance test 36.17 (4.77) 33.25 (6.69) 6.18, <.001 n/a
Achilles reflex (% (n) absent) 54.2 (104) 78.2 (326) FE, <.001 n/a
*

Independent sample t-test

Abbreviations: A = Percentage of cancer survivors without CIN who did not feel the maximum vibration threshold, B = Percentage of cancer survivors with CIN who did not feel the maximum vibration threshold, IP = interphalangeal, n/a = not applicable, SD = standard deviation